Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MOXIFLOXACIN HYDROCHLORIDE TABLETS

Awarded
SPE2DP26F9404Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F9404 to DMS Pharmaceutical Group Inc for the procurement of Moxifloxacin Hydrochloride Tablets. This delivery order, valued at 862.50 dollars, was issued on August 31, 2026, under the broader base administrative contract SPE2DX25D9900. The order specifies the delivery of the pharmaceutical items to AFMEDCOM A4 located in San Antonio, Texas, with a required delivery date of August 31, 2026. The procurement falls under NAICS code 325412 and was managed by the DLA Troop Support Medical Supply Chain. The underlying base contract, SPE2DX25D9900, was originally awarded on April 2, 2025, and serves as a replacement for contract SPE2DX25D9383 under the primary base contract SPE2DX25D9000. This specific award ensures the supply of critical medical tablets identified by NSN 6505015163194.

General Info

DLA awarded DMS Pharmaceutical Group $862.50 for Moxifloxacin tablets delivered to San Antonio.

Contract Value

$862.5

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstaward
High
PDF, High priority: read this firsttask-order-award
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9404 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $862.50 Award Date: 08-31-2026 Delivery order under: SPE2DX25D9900 Line items: - MOXIFLOXACIN HYDROCHLORIDE TABLETS (NSN/Part 6505015163194, PR 7018136220)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS